The Promise and Challenge of Big Data for Pharma
Harvard Business
NOVEMBER 29, 2016
To be sure, anonymized insurance-claims data and electronic health record (EHR) data has been accessed and analyzed for many years. Historically, the pharmaceutical industry has recruited SAS programmers who have executed well-defined analyses of clinical trials in a standardized, efficient manner.
28 
Let's personalize your content